OI Therapy Raised BMD, Not Fracture Benefit - Report - MDSpire
Advertisement
OI Therapy Raised BMD, Not Fracture Benefit
Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.
Clinical Report: OI Therapy Raised BMD, Not Fracture Benefit
Overview
The TOPaZ trial found that teriparatide followed by zoledronic acid improved bone mineral density (BMD) in adults with osteogenesis imperfecta but did not significantly reduce fracture incidence compared to standard care.
Background
Osteogenesis imperfecta (OI) is a genetic disorder characterized by fragile bones and increased fracture risk. Effective management of OI often focuses on improving bone density and reducing fracture rates. The role of pharmacologic therapies, such as teriparatide and zoledronic acid, in achieving these goals remains an important area of investigation.
Data Highlights
Group
Imaging-confirmed Fractures
Bone Mineral Density (BMD)
Teriparatide + Zoledronic Acid
65/176 (36.9%)
Higher at lumbar spine and hip
Standard Care
63/173 (36.4%)
Lower than intervention group
Key Findings
Patient-reported fractures were more common than imaging-confirmed fractures, with no statistically significant difference between groups.
Clinical Implications
The findings suggest that while teriparatide and zoledronic acid can enhance bone mineral density in adults with OI, they may not effectively reduce fracture risk. Clinicians should consider these results when discussing treatment options with patients and managing expectations regarding fracture prevention.
Conclusion
The TOPaZ trial highlights the complexity of treating osteogenesis imperfecta, demonstrating improvements in bone density without corresponding reductions in fracture rates.
A patient may present with a persistent ankle sprain, chronic heel pain, or an acute fracture, but the underlying story is often more complex. Gait abnormalities can contribute to knee, hip, and back pain. Sports injuries may require advanced imaging, physical therapy, and surgical evaluation. Fractures frequently demand coordinated care across multiple services before treatment can begin.
